• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: BIOMARKERS IN MS

NfL – a guide to use in MS practice

May 31, 2023  

Emerging role of CHI3L1 as MS biomarker

May 2, 2023  

AAN 2023 HIGHLIGHTS – WEDNESDAY, APRIL 26

April 26, 2023  

AAN 2023 HIGHLIGHTS – TUESDAY, APRIL 25

April 25, 2023  

AAN 2023 HIGHLIGHTS – MONDAY, APRIL 24

April 24, 2023  

sNfL a biomarker of future disease activity: APLIOS

April 12, 2023  

Putting biomarkers into practice

March 8, 2023  

ECTRIMS 2022 SLIDE DECK

November 10, 2022  

ECTRIMS 2022 HIGHLIGHTS – FRIDAY, OCTOBER 28 EDITION

October 28, 2022  

Three biomarkers of DMT adverse effects proposed

August 25, 2022  
Previous
3
4
5
6
7
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Management of refractory epilepsy: highlights from ILAE 2025 posted on October 29, 2025
  • Revised recommendations on the differential diagnosis of MS posted on July 25, 2023
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions